Nektar Therapeutics (NKTR) Times Interest Earned (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Times Interest Earned came in at -$4.92 in Q1 2026, up 45.08% year-on-year from -$3.39 in Q1 2025, and down 73.64% quarter-over-quarter from -$2.83 in Q4 2025.
Nektar Therapeutics (NKTR) Times Interest Earned (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Times Interest Earned history runs 17 years deep, the most recent figure standing at -$4.92 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 45.08% year-over-year to -$4.92 in Q1 2026; TTM through Mar 2026 was -$4.62, a 11.32% decrease from a year earlier, with the FY2025 full-year figure at -$0.16, down 28.2% from the prior year.
- Times Interest Earned fell to -$4.92 in Q1 2026 per NKTR's latest filing, from -$2.83 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1.41 in Q4 2024 and bottomed at -$21.14 in Q2 2022.
- The 5-year median for Times Interest Earned is -$7.29 (2022), against an average of -$8.27.
- Across the five-year window, Times Interest Earned surged 128.96% in 2024 and slumped 300.39% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$7.29 in 2022, then surged by 33.03% to -$4.88 in 2023, then jumped by 128.96% to $1.41 in 2024, then slumped by 300.39% to -$2.83 in 2025, then plunged by 73.64% to -$4.92 in 2026.
- Per Business Quant, the three latest NKTR Times Interest Earned figures stand at -$4.92 (Q1 2026), -$2.83 (Q4 2025), and -$5.24 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | -4.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.92 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | -5.24 |
| Jun 30, 2025 | -6.72 |
| Mar 31, 2025 | -8.95 |
| Dec 31, 2024 | 1.41 |
| Sep 30, 2024 | -5.71 |
| Jun 30, 2024 | -7.77 |
| Mar 31, 2024 | -6.41 |
| Dec 31, 2023 | -4.88 |
| Sep 30, 2023 | -7.59 |
| Jun 30, 2023 | -8.22 |
| Mar 31, 2023 | -21.03 |
| Dec 31, 2022 | -7.29 |
| Sep 30, 2022 | -7.81 |
| Jun 30, 2022 | -21.14 |
| Mar 31, 2022 | -15.48 |
| Dec 31, 2021 | 5.04 |
| Sep 30, 2021 | -8.87 |
| Jun 30, 2021 | -8.42 |